Tetracore Inc
- View government funding actions
- Rockville, MD 208503986
- Phone: 240-268-5400
- Estimated Number of Employees: 53
- Estimated Annual Receipts: $14,860,271
- Business Start Date: 1998
- Contact Person: John Kelly
- Contact Phone: 240-268-5408
- Contact Email: jkelly@tetracore.com
- Business Structure:
- Corporate Entity (Not Tax Exempt)
- Business Type:
- For Profit Organization
- Manufacturer of Goods
- Subchapter S Corporation
- Industries Served: Other Measuring and Controlling Device Manufacturing, Research and Development in Biotechnology
- Product Areas: LIVE ANIMALS, NOT RAISED FOR FOOD
Sampling of Federal Government Funding Actions/Set Asides
In order by amount of set aside monies.
- $76,786 - Tuesday the 31st of July 2012
Department Of Army
W6QK ACC-APG DIR
TETRODOTOXIN ANTIBODIES - $49,628 - Monday the 30th of July 2012
Food And Drug Administration
DEPT OF HHS/FOOD AND DRUG ADMINISTRATION
CLOSELY FUNCTIONS- TETRACORE RICIN ELISA KIT - $22,215 - Friday the 24th of January 2014
Food And Drug Administration
DEPT OF HHS/FOOD AND DRUG ADMINISTRATION
TAS::75 0600::TAS OTHER, ANTIBODY TEST KITS - $21,545 - Thursday the 19th of July 2012
Department Of Army
W6QM MICC-DUGWAY PROV GRD
B. ANTHRACIS, PRE-COATED (+/-) - $199,823 - Tuesday the 21st of August 2012
Office Of Procurement Operations
SCIENCE AND TECHNOLOGY ACQUISITION DIVISION
DIVISION: CHEMICAL&BIOLOGICAL PPA: CHEMICAL&BIOLOGICAL PROGRAM: BIOASSAYS NEAR TERM PROJECT: BIOASSAYS NEAR TERM PERFORMER: TETRACORE APPROPRIATION YEAR: FY12 (24 FUNDS) LEAD SUPPORT STAFF: JASON RAMAGE, 202-254-6799 ALC: 70-08-1513 DESCRIPTION: THE PURPOSE OF THIS MODIFICATION TO HSHQDC-11-C-00120 IS TO EXTEND THE PERIOD OF PERFORMANCE END DATE FROM 05/29/2012 BY ONE YEAR TO 05/29/2013. TETRACORE HAS IDENTIFIED SEVERAL SOLUTIONS TO ADDRESS PROBLEMS WITH CROSS-REACTIVITY AT HIGH CONCENTRATIONS OF TOXINS IN MULTIPLEX ASSAYS. IMPLEMENTING THESE SOLUTIONS WILL EXTEND THE TIMELINE FOR TASK 1 BY SEVERAL MONTHS. CURRENT DEVELOPMENT RISKS AND MITIGATIONS, AS ADDRESSED IN THE MONTHLY TECHNICAL REPORTS, PREVENT THE COMPLETION OF ALL TASKS ON TIME. THESE INCLUDE THE RECEIPT OF ANTIGEN PANELS FOR INDEPENDENT TESTING AND THE UNCERTAINTY OF CURRENT POLYCLONAL ANTIBODIES FOR BURKHOLDERIA; THESE ANTIBODIES MAY CAUSE SPECIFICITY PROBLEMS IN A MULTIPLEXED FORMAT. WITHOUT APPROPRIATE PANELS, TETRACORE HAS HAD TO RELY ON ITS OWN ANTIGEN STOCKS AND PREPARATIONS CAN VARY SIGNIFICANTLY. IT IS ESSENTIAL TO TEST OPTIMIZED ASSAYS WITH THE GOVERNMENT-SPECIFIED PANEL FOR INDEPENDENT ASSAY EVALUATION. IT IS ESTIMATED THAT AN ADDITIONAL 12 MONTHS WILL BE REQUIRED TO COMPLETE ALL TASKS. THE TOTAL ESTIMATED FUNDS AND TOTAL OBLIGATED FUNDS OF THIS CONTRACT REMAIN UNCHANGED. THE DHS TECHNICAL POINT OF CONTACT IS AS FOLLOWS: DAVID HODGE DEPARTMENT OF HOMELAND SECURITY SCIENCE AND TECHNOLOGY DIRECTORATE WASHINGTON, DC 20528 PHONE: 202.254.5813 E-MAIL: DAVID.HODGE@HQ.DHS.GOV
© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources.
No reliance should be made by readers or Collier Report subscribers.
Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances.
Requests for the modification of displayed information may be made to help.desk@1918.media.